相关实验视频

Updated: Jan 10, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.0K

血清反应模式来评估高级非小细胞肺癌的治疗结果:现实世界的探索性多中心观察队列研究

Alessandra I G Buma1, Femke Laarakker1, Frederik A van Delft2,3

  • 1Department of Respiratory Medicine, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.

Cancers
|November 27, 2025
PubMed
概括

监测血清瘤标记物 (STM) 动态,而不仅仅是单次测量,有助于预测接受免疫检查点抑制剂 (ICI) 的高级非小细胞肺癌 (NSCLC) 患者的治疗结果. 这些模式为临床决策提供了宝贵的见解.

关键词:
在临床决策过程中.免疫检查点抑制剂 免疫检查点抑制剂非小细胞肺癌的肺癌.预后生物标志物 预后生物标志物响应分类 响应分类血清瘤标志物的血清瘤标志物

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.6K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K